Vital KSK Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Vital KSK Holdings heeft een totaal eigen vermogen van ¥109.6B en een totale schuld van ¥7.2B, wat de schuld-eigenvermogensverhouding op 6.6% brengt. De totale activa en totale passiva bedragen respectievelijk ¥317.6B en ¥207.9B. De EBIT Vital KSK Holdings is ¥5.5B waardoor de rentedekking -8.3 is. Het heeft contanten en kortetermijnbeleggingen van ¥19.7B.

Belangrijke informatie

6.6%

Verhouding schuld/eigen vermogen

JP¥7.20b

Schuld

Rente dekkingsratio	-8.3x
Contant	JP¥19.66b
Aandelen	JP¥109.63b
Totaal verplichtingen	JP¥207.94b
Totaal activa	JP¥317.57b

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Aug 07

Recent updates

Vital KSK Holdings' (TSE:3151) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 20

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Aug 07

Impressive Earnings May Not Tell The Whole Story For Vital KSK Holdings (TSE:3151)

May 22

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥198.4B ) 3151 } overtreffen de korte termijn passiva ( ¥189.4B ).

Langlopende schulden: De kortetermijnactiva 3151 ( ¥198.4B ) overtreffen de langetermijnschulden ( ¥18.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 3151 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 3151 is de afgelopen 5 jaar gedaald van 16.8% naar 6.6%.

Schuldendekking: De operationele kasstroom van 3151 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: 3151 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Vital KSK Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Recent updates

Vital KSK Holdings' (TSE:3151) Shareholders May Want To Dig Deeper Than Statutory Profit

Second quarter 2025 earnings released: EPS: JP¥27.90 (vs JP¥28.04 in 2Q 2024)

Upcoming dividend of JP¥21.00 per share

Vital KSK Holdings, Inc. to Report Q2, 2025 Results on Nov 01, 2024

Now 20% overvalued after recent price rise

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Final dividend of JP¥21.00 announced

Vital KSK Holdings, Inc. to Report Q1, 2025 Results on Aug 05, 2024

Impressive Earnings May Not Tell The Whole Story For Vital KSK Holdings (TSE:3151)

Full year 2024 earnings released: EPS: JP¥115 (vs JP¥92.69 in FY 2023)

Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.

Upcoming dividend of JP¥22.00 per share

Vital KSK Holdings, Inc. to Report Fiscal Year 2024 Results on May 13, 2024

Third quarter 2024 earnings released: EPS: JP¥53.65 (vs JP¥19.23 in 3Q 2023)

Vital KSK Holdings, Inc. to Report Q3, 2024 Results on Feb 07, 2024

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.

Second quarter 2024 earnings released: EPS: JP¥28.04 (vs JP¥15.39 in 2Q 2023)

Upcoming dividend of JP¥19.00 per share at 3.9% yield

Vital KSK Holdings, Inc. to Report Q2, 2024 Results on Nov 06, 2023

VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024

First quarter 2024 earnings released: EPS: JP¥17.79 (vs JP¥12.05 in 1Q 2023)

Vital KSK Holdings, Inc. to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings released: EPS: JP¥92.69 (vs JP¥87.88 in FY 2022)

Vital KSK Holdings, Inc., Annual General Meeting, Jun 28, 2023

Upcoming dividend of JP¥27.00 per share at 4.4% yield

Third quarter 2023 earnings released: EPS: JP¥19.23 (vs JP¥19.25 in 3Q 2022)

Vital KSK Holdings, Inc. to Report Q3, 2023 Results on Feb 03, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥15.39 (vs JP¥14.02 in 2Q 2022)

Investor sentiment improved over the past week

Vital KSK Holdings, Inc. to Report Q2, 2023 Results on Nov 07, 2022

Upcoming dividend of JP¥12.00 per share

First quarter 2023 earnings released: EPS: JP¥12.05 (vs JP¥11.66 in 1Q 2022)

Vital KSK Holdings, Inc. to Report Q1, 2023 Results on Aug 02, 2022

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 1,500,000 shares, representing 2.82% for ¥1,029 million.

Full year 2022 earnings released: EPS: JP¥87.88 (vs JP¥21.25 in FY 2021)

Vital KSK Holdings, Inc., Annual General Meeting, Jun 28, 2022

Less than half of directors are independent

Vital KSK Holdings, Inc. to Report Fiscal Year 2022 Results on May 12, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS JP¥14.02 (vs JP¥12.64 in 2Q 2021)

Upcoming dividend of JP¥12.00 per share

First quarter 2022 earnings released: EPS JP¥11.66 (vs JP¥4.68 loss in 1Q 2021)

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 2,000,000 shares, representing 3.62% for ¥2,000 million.

Full year 2021 earnings released: EPS JP¥21.25 (vs JP¥83.34 in FY 2020)

New 90-day low: JP¥790

Third quarter 2021 earnings released: JP¥1.87 loss per share (vs JP¥39.21 profit in 3Q 2020)

New 90-day low: JP¥798

Vital KSK Holdings, Inc. to Report Q3, 2021 Results on Feb 03, 2021

New 90-day low: JP¥839

New 90-day low: JP¥854

Vital KSK Holdings, Inc. to Report Q2, 2021 Results on Nov 05, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven